The FDA warns neurology, nursing, risk managers and surgery personnel that Medtronic Deep Brain Stimulation Lead Kit and Activa Dystonia HDE Kit are recalled due to potential for damage that may cause lead replacement. Background of Deep Brain Stimulation Lead Kit & Activa Dystonia HDE Kit Deep Brain Stimulation systems provide electrical stimulation to selected [...]
Read more
The FDA warns neurology, pharmacy personnel and patients that valproate sodium and related drugs are contraindicated for pregnant women and should not be taken for the prevention of migraine headaches because they can cause lower IQ in their children. Background of Valproate Drugs Valproate drugs are used to treat certain types of epilepsy, manic episodes [...]
Read more
Neurology, Surgery Healthcare Personnel and Risk Managers are informed by the FDA that Vycor Medical Viewsite Brain Access System (VBAS) is recalled because an unidentified black fiber was found on the device that may cause life-threatening adverse events. Background of Vycor Viewsite Brain Access System (VBAS) The Viewsite Brain Access System, by Vycor Medical Inc., [...]
Read more
Neurology, Internal Medicine healthcare personnel and patients are reminded by the FDA that use of Xyrem (sodium oxybate) when combined with alcohol or central nervous system (CNS) depressant drugs can lead to severe breathing problems (respiratory depression) and markedly impair consciousness. Background of Xyrem (sodium oxybate) Xyrem (sodium oxybate), approved by the FDA, is used [...]
Read more
Recent Comments